Doris Molina-Henry
dorismolinahen.bsky.social
Doris Molina-Henry
@dorismolinahen.bsky.social
Neurobiologist and emerging AD clinical trialist focused on recruitment and retention science. Interested in differences in AD biomarkers across demographic subpopulations. #impactAD2020
Excited to share that I’ll be participating in the Equity by Design Panel at the Societal Implications of Geroscience Workshop, hosted by the National Academy of Medicine on Dec 5, 2024! Looking forward to discussing how geroscience impacts aging and society. #Geroscience #HealthyAging
Societal Implications of Geroscience: A Workshop - National Academy of Medicine
Date & Time: December 5, 2024 9:00 AM – 4:30 PM ET Location: In Person & Virtual AARP National Office 601 E St NW, Washington, DC 20049 Register By: In […]
nam.edu
November 28, 2024 at 4:03 PM
Our work, along with that of other outstanding research teams presented at CTAD 2024 in Madrid, is featured on Alzforum! We must address the underlying drivers of dementia in understudied groups. Grateful for the incredible progress being made, thanks to the terrific advances in biomarkers!
Biomarkers Suggest Black and Hispanic People Less Likely to Have Amyloid | ALZFORUM
www.alzforum.org
November 21, 2024 at 5:34 PM
Reposted by Doris Molina-Henry
Another cool write up focused on our recently published guidelines regarding equitable study design and partnering with communities in dementia research. @sarahmwalter.bsky.social

www.healio.com/news/psychia...
Contact the Newsroom
www.healio.com
November 18, 2024 at 10:09 PM
November 19, 2024 at 4:06 AM